grouped.news / most spun

Same story, different headlines

We read each outlet's headline and opening without its name and place it on four measures: sensationalism, loaded language, slant and framing. These are the outlets that sit furthest apart on this story.

6 articles · 5 publishers

Personalized mRNA vaccine cuts melanoma recurrence by 42% in trial

Stands out
BBC News (mildly sensational, one-sided).
Plainest
New York Post, TIME and 2 more.

Where the outlets diverge

Two headlines from opposite ends

  1. Sensationalism · Measured → Sensational

    MeasuredPersonalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trialNBC News Mildly sensationalFirst personalised cancer vaccine cuts risk of disease returning in major trialBBC News

  2. Slant · Straight → One-sided

    StraightFirst-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: studyNew York Post One-sidedFirst personalised cancer vaccine cuts risk of disease returning in major trialBBC News
See how all 5 outlets framed it →Share on X

The measures come from a model reading each report, not from editors, and a position is an estimate. See the most spun story right now.